American Century Companies Inc Pacira Bio Sciences, Inc. Transaction History

American Century Companies Inc

$168 Billion
Q4 2024

A detailed history of American Century Companies Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 135,592 shares of PCRX stock, worth $3.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,592

Previous 92,469 46.64%

Holding current value

$3.45 Million

Previous $1.39 Million 83.48%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$15.3 - $20.33 $659,781 - $876,690	43,123 Added 46.64%	135,592 $2.55 Million
Q3 2024 Nov 12, 2024	BUY	$11.7 - $28.46 $268,760 - $653,754	22,971 Added 33.05%	92,469 $1.39 Million
Q2 2024 Aug 07, 2024	BUY	$25.5 - $31.51 $252,730 - $312,295	9,911 Added 16.63%	69,498 $1.99 Million
Q1 2024 May 14, 2024	BUY	$27.7 - $35.48 $444,751 - $569,666	16,056 Added 36.88%	59,587 $1.74 Million
Q4 2023 Feb 13, 2024	BUY	$26.32 - $34.31 $1.15 Million - $1.49 Million	43,531 New	43,531 $1.47 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $283,391 - $370,311	9,237 Added 43.97%	30,245 $927,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $758,808 - $997,880	21,008 New	21,008 $841,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $506,046 - $581,597	9,876 New	9,876 $525,000
Q2 2021 Aug 05, 2021	SELL	$59.18 - $69.99 $1.03 Million - $1.21 Million	-17,345 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $257,245 - $337,727	-5,097 Reduced 22.71%	17,345 $1.04 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $111,683 - $135,387	-2,149 Reduced 8.74%	22,442 $1.35 Million
Q2 2020 Aug 13, 2020	SELL	$30.8 - $52.47 $732,023 - $1.25 Million	-23,767 Reduced 49.15%	24,591 $1.29 Million
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $331,200 - $591,263	11,662 Added 31.78%	48,358 $1.62 Million
Q4 2019 Feb 12, 2020	SELL	$36.31 - $46.83 $2.08 Million - $2.68 Million	-57,148 Reduced 60.9%	36,696 $1.66 Million
Q3 2019 Nov 13, 2019	BUY	$35.66 - $44.99 $104,341 - $131,640	2,926 Added 3.22%	93,844 $3.57 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $116,841 - $153,264	3,195 Added 3.64%	90,918 $3.95 Million
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $3.2 Million - $3.7 Million	87,723 New	87,723 $0
Q1 2018 May 03, 2018	SELL	$29.98 - $46.35 $1.72 Million - $2.66 Million	-57,322 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$31.85 - $46.95 $207,916 - $306,489	6,528 Added 12.85%	57,322 $2.62 Million
Q3 2017 Nov 01, 2017	BUY	$35.7 - $39.5 $1.81 Million - $2.01 Million	50,794	50,794 $1.91 Million

Others Institutions Holding PCRX

# of Institutions

253

Shares Held

48.8M

Call Options Held

554K

Put Options Held

136K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.17B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Pacira Bio Sciences, Inc. Transaction History